Signaling, Regulation, and Specificity of the Type II p21-activated Kinases
Byung Hak Ha1, Elizabeth M Morse2, Benjamin E Turk1
1From the Departments of Pharmacology and.
Abstract:
The p21-activated kinases (PAKs) are a family of six serine/threonine kinases that act as key effectors of RHO family GTPases in mammalian cells. PAKs are subdivided into two groups: type I PAKs (PAK1, PAK2, and PAK3) and type II PAKs (PAK4, PAK5, and PAK6). Although these groups are involved in common signaling pathways, recent work indicates that the two groups have distinct modes of regulation and have both unique and common substrates. Here, we review recent insights into the molecular level details that govern regulation of type II PAK signaling. We also consider mechanisms by which signal transduction is regulated at the level of substrate specificity. Finally, we discuss the implications of these studies for clinical targeting of these kinases.
Insights
Type II p21-activated kinases (PAKs) are crucial signaling molecules with distinct regulation and substrates compared to Type I PAKs. Understanding their molecular mechanisms is key for developing targeted therapies.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- P21-activated kinases (PAKs) are serine/threonine kinases downstream of RHO GTPases.
- PAKs are classified into Type I (PAK1-3) and Type II (PAK4-6) groups.
- Type I and II PAKs exhibit distinct regulatory mechanisms and substrate specificities.
Purpose of the Study:
- To review recent molecular insights into Type II PAK signaling regulation.
- To explore mechanisms controlling signal transduction and substrate specificity.
- To discuss clinical implications of targeting Type II PAKs.
Main Methods:
- Literature review of recent studies on Type II PAKs.
- Analysis of molecular regulation and signaling pathways.
- Examination of substrate specificity mechanisms.
Main Results:
- Type II PAKs possess unique regulatory modes and substrate interactions.
- Specific molecular details governing Type II PAK signaling are elucidated.
- Mechanisms of substrate specificity in signal transduction are highlighted.
Conclusions:
- Type II PAKs represent distinct signaling nodes with therapeutic potential.
- Targeting Type II PAKs requires understanding their specific regulatory networks.
- Further research into Type II PAKs can inform novel clinical strategies.
Related Concept Videos
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...


